FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2618829115> ?p ?o ?g. }

• W2618829115 abstract "We recently reported that hesperetin-5,7,3'-O-triacetate (HTA) dually inhibited phosphodiesterase (PDE)3/4 with a therapeutic ratio of 20.8. The application and development of PDE4 inhibitors for treating asthma or COPD are limited by their side effects, such as nausea, vomiting and gastric hypersecretion. PDE4 inhibitors were reported to reverse xylazine/ketamine-induced anesthesia in rats and triggered vomiting in ferrets. Thus the reversing effect of HTA on xylazine/ketamine-induced anesthesia in mice was studied to assess emetic effect of HTA. The aim of this study was to prove the therapeutic effect of HTA without vomiting effect at an effective dose for treating COPD.Ten female BALB/c mice in each group were sensitized by ovalbumin (OVA) on days 0 and 14. On day 21, these mice were emphasized the sensitization by Freund's complete adjuvant. Mice were challenged by 1% OVA nebulization on days 28, 29, and 30. Airway hyperresponsiveness (AHR) was assessed on day 32 in each group, using the FlexiVent system to determine airway resistance (RL) and lung dynamic compliance (Cdyn) in anesthetized ovalbumin (OVA)-sensitized and challenged mice. Each group was orally administered HTA (10 ~ 100 μmol/kg), roflumilast (1 and 5 mg/kg) or vehicles (controls) 2 h before and 6 and 24 h after OVA provocation. For comparison, sham-treated mice were challenged with saline instead of 1% OVA. The ability to reverse xylazine/ketamine-induced anesthesia by HTA or roflumilast for 3 h was determined in normal mice. We used roflumilast, a selective PDE4 inhibitor and bronchodilator for severe COPD approved by the US Food and Drug Administration, as a reference drug.In the results, HTA (100 μmol/kg, p.o.) or roflumilast (5 mg/kg, p.o.) significantly suppressed all RL values of MCh at 0.78 ~ 25 mg/mL and enhanced Cdyn values of MCh at 3.125 ~ 25 mg/mL compared to OVA-sensitized and -challenged control mice. Orally administered 1, 3 or 10 mg/kg roflumilast, but not 30 or 100 μmol/kg HTA, significantly reversed xylazine/ketamine-induced anesthesia.In contrast to roflumilast, HTA may ameliorate COPD but induce few side effects of nausea, vomiting and gastric hypersecretion at an effective dose for treating COPD, because HTA did not reverse xylazine/ketamine-induced anesthesia in mice." @default.
• W2618829115 created "2017-06-05" @default.
• W2618829115 creator A5027157431 @default.
• W2618829115 creator A5046502823 @default.
• W2618829115 creator A5067223942 @default.
• W2618829115 creator A5070625040 @default.
• W2618829115 date "2017-05-30" @default.
• W2618829115 modified "2023-10-08" @default.
• W2618829115 title "Hesperetin-5,7,3’-O-triacetate suppresses airway hyperresponsiveness in ovalbumin-sensitized and challenged mice without reversing xylazine/ketamine-induced anesthesia in normal mice" @default.
• W2618829115 cites W1531823431 @default.
• W2618829115 cites W1954701421 @default.
• W2618829115 cites W1968206308 @default.
• W2618829115 cites W2016761176 @default.
• W2618829115 cites W2043379639 @default.
• W2618829115 cites W2046625035 @default.
• W2618829115 cites W2057912408 @default.
• W2618829115 cites W2059828011 @default.
• W2618829115 cites W2068788937 @default.
• W2618829115 cites W2071333842 @default.
• W2618829115 cites W2090334210 @default.
• W2618829115 cites W2093600587 @default.
• W2618829115 cites W2112941906 @default.
• W2618829115 cites W2126118351 @default.
• W2618829115 cites W2152333598 @default.
• W2618829115 cites W2152554537 @default.
• W2618829115 cites W2153231621 @default.
• W2618829115 cites W2167442442 @default.
• W2618829115 cites W2170451911 @default.
• W2618829115 cites W2174449637 @default.
• W2618829115 cites W2951849123 @default.
• W2618829115 cites W4238210836 @default.
• W2618829115 cites W4256102116 @default.
• W2618829115 doi "https://doi.org/10.1186/s40360-017-0146-5" @default.
• W2618829115 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5450382" @default.
• W2618829115 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28558784" @default.
• W2618829115 hasPublicationYear "2017" @default.
• W2618829115 type Work @default.
• W2618829115 sameAs 2618829115 @default.
• W2618829115 citedByCount "5" @default.
• W2618829115 countsByYear W26188291152019 @default.
• W2618829115 countsByYear W26188291152020 @default.
• W2618829115 countsByYear W26188291152021 @default.
• W2618829115 crossrefType "journal-article" @default.
• W2618829115 hasAuthorship W2618829115A5027157431 @default.
• W2618829115 hasAuthorship W2618829115A5046502823 @default.
• W2618829115 hasAuthorship W2618829115A5067223942 @default.
• W2618829115 hasAuthorship W2618829115A5070625040 @default.
• W2618829115 hasBestOaLocation W26188291151 @default.
• W2618829115 hasConcept C126322002 @default.
• W2618829115 hasConcept C203014093 @default.
• W2618829115 hasConcept C2776217527 @default.
• W2618829115 hasConcept C2776780178 @default.
• W2618829115 hasConcept C2776946954 @default.
• W2618829115 hasConcept C2778926808 @default.
• W2618829115 hasConcept C2779591255 @default.
• W2618829115 hasConcept C2780795376 @default.
• W2618829115 hasConcept C42219234 @default.
• W2618829115 hasConcept C71924100 @default.
• W2618829115 hasConcept C8891405 @default.
• W2618829115 hasConcept C98274493 @default.
• W2618829115 hasConceptScore W2618829115C126322002 @default.
• W2618829115 hasConceptScore W2618829115C203014093 @default.
• W2618829115 hasConceptScore W2618829115C2776217527 @default.
• W2618829115 hasConceptScore W2618829115C2776780178 @default.
• W2618829115 hasConceptScore W2618829115C2776946954 @default.
• W2618829115 hasConceptScore W2618829115C2778926808 @default.
• W2618829115 hasConceptScore W2618829115C2779591255 @default.
• W2618829115 hasConceptScore W2618829115C2780795376 @default.
• W2618829115 hasConceptScore W2618829115C42219234 @default.
• W2618829115 hasConceptScore W2618829115C71924100 @default.
• W2618829115 hasConceptScore W2618829115C8891405 @default.
• W2618829115 hasConceptScore W2618829115C98274493 @default.
• W2618829115 hasIssue "1" @default.
• W2618829115 hasLocation W26188291151 @default.
• W2618829115 hasLocation W26188291152 @default.
• W2618829115 hasLocation W26188291153 @default.
• W2618829115 hasLocation W26188291154 @default.
• W2618829115 hasLocation W26188291155 @default.
• W2618829115 hasOpenAccess W2618829115 @default.
• W2618829115 hasPrimaryLocation W26188291151 @default.
• W2618829115 hasRelatedWork W162026588 @default.
• W2618829115 hasRelatedWork W2010261788 @default.
• W2618829115 hasRelatedWork W2054111846 @default.
• W2618829115 hasRelatedWork W2157145132 @default.
• W2618829115 hasRelatedWork W2549267692 @default.
• W2618829115 hasRelatedWork W2887874683 @default.
• W2618829115 hasRelatedWork W2912754050 @default.
• W2618829115 hasRelatedWork W3180011473 @default.
• W2618829115 hasRelatedWork W55053370 @default.
• W2618829115 hasRelatedWork W562389989 @default.
• W2618829115 hasVolume "18" @default.
• W2618829115 isParatext "false" @default.
• W2618829115 isRetracted "false" @default.
• W2618829115 magId "2618829115" @default.
• W2618829115 workType "article" @default.